DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Fortis Healthcare Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·13 Oct 2026, 5:44 am

Fortis Healthcare

Fortis Healthcare Limited has submitted a certificate to the stock exchanges in compliance with SEBI's regulations regarding Depositories and Participants. This filing is a standard administrative requirement for listed companies to ensure transparency and adherence to regulatory norms regarding their shareholding structure and depository operations.

For investors, this announcement is largely procedural and does not signal any immediate operational changes or significant news. It confirms that the company is maintaining proper records with its depository participants, which is a routine part of corporate governance for any listed entity.

Investors should monitor the company's future disclosures for any material updates. While this filing itself is neutral, keeping an eye on broader market trends and the company's quarterly performance remains essential for making informed investment decisions.